Market Tracker

08/30 6:49am ET

MannKind Corp (NASDAQ:MNKD)

0.745
Delayed Data
As of Aug 29
 -0.0436 / -5.53%
Today’s Change
0.64
Today|||52-Week Range
4.07
-48.62%
Year-to-Date
Here's How MannKind Corp. Could Stage a Miraculous Comeback
Aug 29 / MotleyFool.com - Paid Partner Content
3 Stocks We Wouldn't Touch With a 10-Foot Pole
Aug 22 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close0.79
Today’s open0.80
Day’s range0.72 - 0.80
Volume4,927,443
Average volume (3 months)3,894,317
Market cap$377.0M
Dividend yield--
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.73%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc+0.33+2.60%
SRNESorrento Therapeutic...-0.09-1.36%
OMEDOncoMed Pharmaceutic...+0.12+1.16%
TRVNTrevena Inc-0.07-0.99%
Data as of 08/29/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts